What is a typical prednisone (corticosteroid) taper schedule?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prednisone Tapering Schedule

The optimal prednisone taper involves gradually reducing the dose to 10 mg/day within 4-8 weeks, then reducing by 1 mg every 4 weeks until discontinuation. 1

General Principles

  • Single daily dosing is preferred over divided doses except in special situations such as prominent night pain while on low doses (<5 mg daily) 1, 2
  • For courses longer than 3 weeks, tapering is necessary to prevent adrenal insufficiency 1, 2
  • Morning administration (before 9 am) is recommended to minimize adrenal suppression, as this coincides with the body's natural cortisol peak 3

Specific Tapering Schedules Based on Initial Dose

For High Initial Doses (>30 mg/day)

  • Reduce the dose to 10 mg/day within 4-8 weeks 1
  • Then reduce by 1 mg every 4 weeks until discontinuation 1
  • For inflammatory conditions: Start with prednisone 20 mg daily for 2-4 weeks, then taper over 4-8 weeks 1

For Medium Initial Doses (10-30 mg/day)

  • Taper by 5 mg every week until reaching 10 mg/day 1, 2
  • Then slow the taper to 2.5 mg/week until reaching 5 mg/day 1
  • At 5 mg/day, further slow the taper to 1 mg decrements every 2-4 weeks 2

For Low Doses (<10 mg/day)

  • Taper by 1 mg every 4 weeks 1, 2
  • Alternative approach: Use 1.25 mg decrements with alternate-day schedules (e.g., 10/7.5 mg alternate days) 1

Disease-Specific Recommendations

For Autoimmune Hepatitis

  • For adults: Start with prednisone 30 mg/day, taper to 10 mg/day for maintenance 1
  • For children: Start with 1-2 mg/kg/day (up to 60 mg/day), taper over 6-8 weeks to 0.1-0.2 mg/kg daily or 5 mg daily 4

For Polymyalgia Rheumatica

  • Initial dose: 12.5-25 mg prednisone equivalent daily 1, 2
  • Initial tapering: Reduce to 10 mg/day within 4-8 weeks 1, 2
  • Maintenance tapering: Reduce by 1 mg every 4 weeks until discontinuation 1, 2

For Inflammatory Myopathies

  • Initial dose: 0.5-1 mg/kg/day (typically 60-80 mg/day) 1
  • Taper by 10 mg every 2 weeks until reaching 30 mg/day 1
  • Then taper by 5 mg every 2 weeks until reaching 20 mg/day 1
  • Then taper by 2.5 mg every 2 weeks until reaching 10 mg/day 1
  • At 10 mg/day, slow to 1 mg every 2-4 weeks until completed 1

Managing Relapse During Tapering

  • Return to the pre-relapse dose if symptoms recur 1, 2
  • Gradually decrease within 4-8 weeks to the dose at which relapse occurred 1, 2
  • Consider adding steroid-sparing agents if multiple relapses occur 1, 2

Alternate Day Therapy

  • Alternate day therapy involves administering twice the usual daily dose every other morning 3
  • This approach helps minimize pituitary-adrenal suppression while maintaining therapeutic effects 3
  • The rationale is based on the fact that anti-inflammatory effects persist longer than metabolic effects, and the off-day allows for more normal hypothalamic-pituitary-adrenal activity 3

Common Pitfalls to Avoid

  • Tapering too quickly, which may lead to disease flare or adrenal insufficiency 1, 2
  • Not providing patients with clear instructions about tapering schedule 2
  • Failing to monitor for steroid-related side effects during tapering 1
  • Abrupt withdrawal of therapy, which should be avoided as stated in the FDA label 3

Evidence on Tapering vs. Non-Tapering

  • For acute asthma exacerbations, studies have shown no significant difference in relapse rates or adrenal suppression between patients receiving an 8-day tapering course versus a fixed 8-day course of 40 mg/day 5, 6, 7
  • For rheumatoid arthritis patients on tocilizumab, continuing low-dose prednisone (5 mg/day) provided better disease control than tapering, although two-thirds of patients were able to safely taper their glucocorticoid dose 8

References

Guideline

Prednisone Tapering Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prednisone Tapering Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Double-blind trial of steroid tapering in acute asthma.

Lancet (London, England), 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.